Терапевтический архив (Dec 2015)

FIP1L1-PDGFRА-positive myeloproliferative disease with eosinophilia: A rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapy

  • I S Nemchenko,
  • A G Turkina,
  • E Yu Chelysheva,
  • G M Galstyan,
  • A M Kovrigina,
  • N K Khuazheva,
  • V G Savchenko

Journal volume & issue
Vol. 87, no. 12
pp. 89 – 95

Abstract

Read online

The described case of FIP1L1-PDGFRА-positive myeloproliferative disease is characterized by an atypical aggressive course to develop severe specific complications as injuries to the brain, heart, lung, and intestine. Pathogenetic therapy with imatinib could stabilize a patient’s state, but failed to produce a complete hematological response. Switching from imatinib to dasatinib could produce sustained clinical, hematological, and molecular remissions.

Keywords